Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, Ballas ZK, Bonilla FA, Ochs HD, Walter JE. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37(3):287–94. https://doi.org/10.1007/s10875-017-0374-x.
Article CAS PubMed PubMed Central Google Scholar
Battat R, Dulai PS, Jairath V, Vande Casteele N. A product review of vedolizumab in inflammatory bowel disease. Hum Vaccin Immunother. 2019;15(10):2482–90. https://doi.org/10.1080/21645515.2019.1591139.
Article PubMed PubMed Central Google Scholar
Khan F, Person H, Dekio F, Ogawa M, Ho HE, Dunkin D, Secord E, Cunningham-Rundles C, Ward SC. Crohn’s-like Enteritis in X-Linked agammaglobulinemia: a Case Series and systematic review. J Allergy Clin Immunol Pract. 2021;9(9):3466–78. https://doi.org/10.1016/j.jaip.2021.04.070.
Article CAS PubMed PubMed Central Google Scholar
Çekiç Şükrü, Özgür T, Karalı Y, Ozkan T, Kilic S. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient? Turk J Pediatr. 2019;61:937. https://doi.org/10.24953/turkjped.2019.06.016.
Deng F, Wang H, Wang X. Chronic diarrhea with Villous Blunting of the Small Intestine under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked agammaglobulinemia: a Case Series. J Asthma Allergy. 2023;16:997–1006. PMID: 37772267; PMCID: PMC10522781.
Article PubMed PubMed Central Google Scholar
Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol. 2001;108(6):1012-20. https://doi.org/10.1067/mai.2001.120133. PMID: 11742281.
Molina J, Casin I, Hausfater P, Giretti E, Welker Y, Decazes J, Garrait V, Lagrange P, Modaï J. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS. 1995;9(8):881-5. https://doi.org/10.1097/00002030-199508000-00008. PMID: 7576322.
Grammatikos A, Thomas M, Johnston S, Moghaddas F, Albur M, Yong P, Buckland M, Grigoriadou S, Whyte AF, Herwadkar A, Gompels M. Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: a UK national case-series and review of the literature. J Allergy Clin Immunol Pract. 2023;11(9):2948–e29544. Epub 2023 Jun 8. PMID: 37301434.
Kochar B, Pate V, Kappelman MD, Long MD, Ananthakrishnan AN, Chan AT, Sandler RS. Vedolizumab is Associated with a lower risk of Serious infections Than Anti-tumor necrosis factor agents in older adults. Clin Gastroenterol Hepatol. 2022;20(6):1299–e13055. Epub 2021 Sep 3. PMID: 34481954; PMCID: PMC8891388.
留言 (0)